Juxtapid

Active Ingredient(s): Lomitapide Medylate
FDA Approved: * December 21, 2012
Pharm Company: * AEGERION PHARMACEUTICALS INC
Category: Cholesterol

Lomitapide , sold under the brand name Juxtapid in the US and as Lojuxta in the EU) is a medication used as a lipid-lowering agent for the treatment of familial hypercholesterolemia, developed by Aegerion Pharmaceuticals.[3] It has been tested in clinical trials as single treatment and in combinations with atorvastatin, ezetimibe and fenofibrate.[4][5] The US Food and Drug Administration (FDA) approved lomitapide on 21 December 2012, as an orph... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Juxtapid 5 mg Oral Capsule
NDC: 76431-105
Labeler:
Aegerion Pharmaceuticals, Inc.
Juxtapid 10 mg Oral Capsule
NDC: 76431-110
Labeler:
Aegerion Pharmaceuticals, Inc.
Juxtapid 20 mg Oral Capsule
NDC: 76431-120
Labeler:
Aegerion Pharmaceuticals, Inc.
Juxtapid 30 mg Oral Capsule
NDC: 76431-130
Labeler:
Aegerion Pharmaceuticals, Inc.
Juxtapid 40 mg Oral Capsule
NDC: 76431-140
Labeler:
Aegerion Pharmaceuticals, Inc.
Juxtapid 60 mg Oral Capsule
NDC: 76431-160
Labeler:
Aegerion Pharmaceuticals, Inc.